Dan Spiegelman

Mark Schoenebaum, M.D., of Evercore ISI met with BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)’s CFO Dan Spiegelman, Site Head of BioMarin Nederland and DMD lead Scott Clarke and Head of IR Traci McCarty. In an email sent to investors, the analyst shared six key highlights from his meeting....